Jiangzhong Pharmaceutical Co Ltd (600750) - Total Assets
Based on the latest financial reports, Jiangzhong Pharmaceutical Co Ltd (600750) holds total assets worth CN¥6.88 Billion CNY (≈ $1.01 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Jiangzhong Pharmaceutical Co Ltd (600750) shareholders funds for net asset value and shareholders' equity analysis.
Jiangzhong Pharmaceutical Co Ltd - Total Assets Trend (1993–2025)
This chart illustrates how Jiangzhong Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.
Jiangzhong Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Jiangzhong Pharmaceutical Co Ltd's total assets of CN¥6.88 Billion consist of 49.8% current assets and 50.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.3% |
| Accounts Receivable | CN¥851.49 Million | 12.4% |
| Inventory | CN¥454.08 Million | 6.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥424.03 Million | 6.2% |
| Goodwill | CN¥52.37 Million | 0.8% |
Asset Composition Trend (1993–2025)
This chart illustrates how Jiangzhong Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Jiangzhong Pharmaceutical Co Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jiangzhong Pharmaceutical Co Ltd's current assets represent 49.8% of total assets in 2025, an increase from 32.1% in 1993.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, up from 6.4% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 1993.
- Asset Diversification: The largest asset category is accounts receivable at 12.4% of total assets.
Jiangzhong Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Jiangzhong Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥21.15 Billion |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs93.93 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.02 Billion |
Jiangzhong Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 1.40 | 5.95 |
| Quick Ratio | 1.56 | 1.14 | 5.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.52 Billion | CN¥716.43 Million | CN¥2.85 Billion |
Jiangzhong Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Jiangzhong Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.24 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | 5.7% |
| Total Assets | CN¥6.88 Billion |
| Market Capitalization | $2.23 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Jiangzhong Pharmaceutical Co Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jiangzhong Pharmaceutical Co Ltd's assets grew by 5.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jiangzhong Pharmaceutical Co Ltd (1993–2025)
The table below shows the annual total assets of Jiangzhong Pharmaceutical Co Ltd from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.88 Billion ≈ $1.01 Billion |
+5.73% |
| 2024-12-31 | CN¥6.51 Billion ≈ $952.32 Million |
+1.66% |
| 2023-12-31 | CN¥6.40 Billion ≈ $936.73 Million |
+1.99% |
| 2022-12-31 | CN¥6.28 Billion ≈ $918.41 Million |
+4.65% |
| 2021-12-31 | CN¥6.00 Billion ≈ $877.64 Million |
+21.81% |
| 2020-12-31 | CN¥4.92 Billion ≈ $720.47 Million |
+3.45% |
| 2019-12-31 | CN¥4.76 Billion ≈ $696.42 Million |
+24.69% |
| 2018-12-31 | CN¥3.82 Billion ≈ $558.54 Million |
+13.46% |
| 2017-12-31 | CN¥3.36 Billion ≈ $492.27 Million |
+9.73% |
| 2016-12-31 | CN¥3.07 Billion ≈ $448.62 Million |
+14.47% |
| 2015-12-31 | CN¥2.68 Billion ≈ $391.92 Million |
-19.50% |
| 2014-12-31 | CN¥3.33 Billion ≈ $486.85 Million |
+11.18% |
| 2013-12-31 | CN¥2.99 Billion ≈ $437.88 Million |
-7.32% |
| 2012-12-31 | CN¥3.23 Billion ≈ $472.48 Million |
+24.72% |
| 2011-12-31 | CN¥2.59 Billion ≈ $378.83 Million |
+3.30% |
| 2010-12-31 | CN¥2.51 Billion ≈ $366.71 Million |
+56.86% |
| 2009-12-31 | CN¥1.60 Billion ≈ $233.79 Million |
+0.73% |
| 2008-12-31 | CN¥1.59 Billion ≈ $232.10 Million |
+29.81% |
| 2007-12-31 | CN¥1.22 Billion ≈ $178.80 Million |
-7.33% |
| 2006-12-31 | CN¥1.32 Billion ≈ $192.95 Million |
+14.53% |
| 2005-12-31 | CN¥1.15 Billion ≈ $168.48 Million |
-1.14% |
| 2004-12-31 | CN¥1.16 Billion ≈ $170.41 Million |
+18.00% |
| 2003-12-31 | CN¥986.94 Million ≈ $144.42 Million |
+33.23% |
| 2002-12-31 | CN¥740.78 Million ≈ $108.40 Million |
+15.88% |
| 2001-12-31 | CN¥639.27 Million ≈ $93.55 Million |
-9.77% |
| 2000-12-31 | CN¥708.47 Million ≈ $103.67 Million |
+4.57% |
| 1999-12-31 | CN¥677.53 Million ≈ $99.14 Million |
+60.83% |
| 1998-12-31 | CN¥421.28 Million ≈ $61.65 Million |
+2.25% |
| 1997-12-31 | CN¥412.00 Million ≈ $60.29 Million |
+27.26% |
| 1996-12-31 | CN¥323.76 Million ≈ $47.38 Million |
+200.86% |
| 1995-12-31 | CN¥107.61 Million ≈ $15.75 Million |
+29.28% |
| 1994-12-31 | CN¥83.24 Million ≈ $12.18 Million |
+9.79% |
| 1993-12-31 | CN¥75.82 Million ≈ $11.10 Million |
-- |
About Jiangzhong Pharmaceutical Co Ltd
China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsu… Read more